Valuation: GSK plc

Capitalization 57.64B 77.19B 66.48B 61.86B 106B 6,638B 118B 750B 283B 3,105B 290B 284B 11,494B P/E ratio 2025 *
10x
P/E ratio 2026 * 8.89x
Enterprise value 70.94B 95.01B 81.82B 76.14B 130B 8,170B 146B 923B 349B 3,822B 356B 349B 14,146B EV / Sales 2025 *
2.22x
EV / Sales 2026 * 2.02x
Free-Float
94.52%
Yield 2025 *
4.56%
Yield 2026 * 4.84%
More valuation ratios * Estimated data
Dynamic Chart
1 day-1.23%
1 week-0.81%
Current month+0.90%
1 month-5.59%
3 months+4.20%
6 months+5.65%
Current year+4.16%
More quotes
1 week 1,401.5
Extreme 1401.5
1,495.5
1 month 1,380.5
Extreme 1380.5
1,507
Current year 1,242.5
Extreme 1242.5
1,560.5
1 year 1,242.5
Extreme 1242.5
1,678.68
3 years 1,242.5
Extreme 1242.5
1,823.5
5 years 1,242.5
Extreme 1242.5
3,408.16
10 years 1,242.5
Extreme 1242.5
3,408.16
More quotes
Manager TitleAgeSince
Chief Executive Officer 56 2017-03-31
Director of Finance/CFO 63 2023-04-30
Compliance Officer - 2018-07-31
Director TitleAgeSince
Director/Board Member 56 2016-12-31
Director/Board Member 63 2017-12-31
Chairman 67 2019-08-31
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-1.54%-0.81%-6.38%-34.74% 77.51B
-2.91%-0.35%-18.46%+133.71% 718B
-1.14%-0.32%+4.05%-12.87% 377B
-2.38%-2.23%+10.42%+20.78% 338B
-2.29%-3.74%-55.50%+3.48% 308B
-1.05%-1.05%-1.43%-23.16% 259B
-0.38%-1.69%-3.07%+16.27% 237B
-1.56%+1.51%-13.28%-5.53% 222B
-2.74%+0.34%-36.27%-14.02% 210B
-1.23%-1.26%-11.18%+17.92% 160B
Average -1.71%+1.31%-13.11%+10.18% 290.75B
Weighted average by Cap. -1.94%+1.56%-13.50%+32.00%
See all sector performances

Financials

2025 *2026 *
Net sales 32B 42.86B 36.91B 34.35B 58.82B 3,686B 65.78B 416B 157B 1,724B 161B 157B 6,382B 33.75B 45.21B 38.93B 36.23B 62.04B 3,887B 69.38B 439B 166B 1,818B 170B 166B 6,731B
Net income 5.71B 7.65B 6.59B 6.13B 10.49B 658B 11.74B 74.26B 28.08B 308B 28.68B 28.09B 1,139B 6.43B 8.61B 7.41B 6.9B 11.81B 740B 13.21B 83.6B 31.62B 346B 32.29B 31.63B 1,282B
Net Debt 13.3B 17.82B 15.34B 14.28B 24.45B 1,532B 27.35B 173B 65.43B 717B 66.83B 65.45B 2,653B 10.64B 14.26B 12.28B 11.42B 19.56B 1,226B 21.88B 138B 52.35B 573B 53.47B 52.36B 2,122B
More financial data * Estimated data
Logo GSK plc
GSK plc is a global biopharma company. The Company’s segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. Its product areas include vaccines, specialty medicines, and general medicine. It is also focused on addressing the unmet treatment needs of patients with respiratory and inflammatory conditions. Its vaccine portfolio includes over 20 vaccines that help to protect people from a range of diseases and infections, including meningitis, shingles and flu, among others. Its specialty medicines are also engaged in developing medicines for respiratory disease and HIV. Its general medicines include inhaled medicines for asthma and chronic obstructive pulmonary disease, antibiotics, and medicines for skin diseases. It is advancing oligonucleotide therapeutics in chronic hepatitis B and steatotic liver disease as well as other therapeutic areas beyond liver disease.
Employees
68,629
More about the company
Date Price Change Volume
25-07-15 1,402.50 p -1.54% 11,371,670
25-07-14 1,424.50 p +1.14% 6,480,863
25-07-11 1,408.50 p -3.16% 8,542,394
25-07-10 1,454.50 p +2.07% 7,057,049
25-07-09 1,425.00 p +0.78% 7,848,611

Delayed Quote London S.E., July 15, 2025 at 11:35 am EDT

More quotes
Trading Rating
Investor Rating
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
14.24GBP
Average target price
16.30GBP
Spread / Average Target
+14.41%
Consensus

Quarterly revenue - Rate of surprise